| Title | NeuroImmunoModulation |
| Abbreviation | NeuroImmunoModulation |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Endocrine and Autonomic Systems (Q3); Endocrinology (Q3); Immunology (Q3); Neurology (Q3) |
| h-index | 74 |
| Overall Rank/Ranking | 8947 |
| SCImago Journal Rank (SJR) | 0.6 |
| Impact Score | 2.38 |
| Publisher | S. Karger AG |
| Country | Switzerland |
| ISSN | 14230216, 10217401 |
| Best Quartile | Q3 |
| Coverage History | 1994-2002, 2004-2023 |
The rapidly expanding area of research known as neuroimmunomodulation explores the way in which the nervous system interacts with the immune system via neural, hormonal, and paracrine actions. Encompassing both basic and clinical research, "Neuroimmunomodulation" reports on all aspects of these interactions. Basic investigations consider all neural and humoral networks from molecular genetics through cell regulation to integrative systems of the body. The journal also aims to clarify the basic mechanisms involved in the pathogenesis of the CNS pathology in AIDS patients and in various neurodegenerative diseases. Although primarily devoted to research articles, timely reviews are published on a regular basis.
NeuroImmunoModulation is a journal covering the technologies/fields/categories related to Endocrine and Autonomic Systems (Q3); Endocrinology (Q3); Immunology (Q3); Neurology (Q3). It is published by S. Karger AG. The overall rank of NeuroImmunoModulation is 8947. According to SCImago Journal Rank (SJR), this journal is ranked 0.6. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 74. The best quartile for this journal is Q3.
The ISSN of NeuroImmunoModulation journal is 14230216, 10217401. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. NeuroImmunoModulation is cited by a total of 268 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of NeuroImmunoModulation is 2.38, which is computed in 2024 as per its definition. NeuroImmunoModulation IF is decreased by a factor of 0.15 and approximate percentage change is -5.93% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of NeuroImmunoModulation is 2.38. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.38 |
| 2022 | 2.53 |
| 2021 | 3.06 |
| 2020 | 2.47 |
| 2019 | 1.56 |
| 2018 | 1.77 |
| 2017 | 1.84 |
| 2016 | 3.18 |
| 2015 | 2.31 |
| 2014 | 2.12 |
NeuroImmunoModulation has an h-index of 74. It means 74 articles of this journal have more than 74 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of NeuroImmunoModulation is 14230216, 10217401. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of NeuroImmunoModulation is 8947. According to SCImago Journal Rank (SJR), this journal is ranked 0.6. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.6 |
| 2022 | 0.663 |
| 2021 | 0.548 |
| 2020 | 0.635 |
| 2019 | 0.488 |
| 2018 | 0.530 |
| 2017 | 1.064 |
| 2016 | 1.060 |
| 2015 | 0.878 |
| 2014 | 0.735 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 8947 |
| 2022 | 7623 |
| 2021 | 9138 |
| 2020 | 7943 |
| 2019 | 10009 |
| 2018 | 9058 |
| 2017 | 4005 |
| 2016 | 4052 |
| 2015 | 5261 |
| 2014 | 6316 |
NeuroImmunoModulation is published by S. Karger AG. It's publishing house is located in Switzerland. Coverage history of this journal is as following: 1994-2002, 2004-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of NeuroImmunoModulation is NeuroImmunoModulation. This abbreviation ('NeuroImmunoModulation') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Endocrine and Autonomic Systems (Q3); Endocrinology (Q3); Immunology (Q3); Neurology (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
NeuroImmunoModulation latest impact IF is 2.38. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.18 (2016) and 1.56 (2019), respectively, in the last 10 years. Moreover, its average IS is 2.32 in the previous 10 years.
The NeuroImmunoModulation has an SJR (SCImago Journal Rank) of 0.6, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.064 in 2017 and the lowest being 0.488 in 2019. Furthermore, the average SJR of the NeuroImmunoModulation over the previous 10-year period stands at 2.32.
The latest h-index of the NeuroImmunoModulation is 74.
The NeuroImmunoModulation is published by the S. Karger AG, with its country of publication being the Switzerland.
The NeuroImmunoModulation is currently ranked 8947 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 4005 in 2017 and its lowest position of 10009 in 2019.
The standard ISO4 abbreviation for the NeuroImmunoModulation is NeuroImmunoModulation.
NeuroImmunoModulation is classified as a journal that the S. Karger AG publishes.
The NeuroImmunoModulation encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The NeuroImmunoModulation is assigned the following International Standard Serial Numbers (ISSN): 14230216, 10217401.
The best quartile for the NeuroImmunoModulation is Q3 (2023).
The NeuroImmunoModulation coverage history can be summarized as follows: 1994-2002, 2004-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| European Union Politics | journal | 2569 | SAGE Publications Ltd | 75 | 3.24 |
| Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
| Journal of Geriatric Physical Therapy | journal | 9578 | Lippincott Williams and Wilkins Ltd. | 47 | 1.23 |
| Criminal Justice Review | journal | 12054 | SAGE Publications Inc. | 42 | 1.10 |
| International Journal of Mathematical Education in Science and Technology | journal | 8417 | Taylor and Francis Ltd. | 42 | 1.17 |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| Journal, Indian Academy of Clinical Medicine | journal | 26979 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Korean Journal of Applied Microbiology and Biotechnology | journal | 22033 | Korean Society for Applied Microbiology | 0 | 0.00 |
| Proteomics - Clinical Applications | journal | 9438 | Wiley-VCH Verlag | 64 | 2.28 |
| SPE International Formation Damage Control Symposium Proceedings | conference and proceedings | 21934 | 16 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.38 |
| 2022 | 2.53 |
| 2021 | 3.06 |
| 2020 | 2.47 |
| 2019 | 1.56 |
| 2018 | 1.77 |
| 2017 | 1.84 |
| 2016 | 3.18 |
| 2015 | 2.31 |
| 2014 | 2.12 |
